Malaria Is Associated with Diminished Levels of Ascorbic Acid: A Systematic Review and Meta-Analysis
Antioxidants & Redox Signaling · 2024-03 · 40 (7-9) · 460-469
DOI: 10.1089/ars.2023.0306 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 19.06.2023. Verfasst von Manas Kotepui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Technology, School of Allied Health Sciences, Walailak University, Thai Buri, Nakhon Si Thammarat, Thailand. Hauptthemen laut MEDLINE: Malaria, Ascorbic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Background
It is still unclear how ascorbic acid levels relate to the pathogenesis of malaria. This systematic review synthesized different ascorbic acid levels in malaria patients with different severity levels of malaria and Plasmodium species.
Methods
The systematic review protocol was registered in the PROSPERO database (CRD42023394849). A systematic search of PubMed, Embase, MEDLINE, Ovid, Scopus, and Google Scholar was conducted to identify studies that reported ascorbic acid and malaria. The pooled standardized mean difference (Cohen's d ) with 95% confidence intervals (CIs) was calculated using the random-effects model.
Results
A total of 1480 articles were obtained from the searches of the databases, and 30 studies were included for syntheses. The meta-analysis revealed that patients with malaria had lower levels of ascorbic acid than those without malaria or uninfected controls ( p < 0.01, Cohen's d = −3.71, 95% CI = −4.44 to −2.98, I 2 = 98.87%, 30 studies). Comparable levels of ascorbic acid were observed between patients with severe malaria and those with nonsevere malaria ( p = 0.06, Cohen's d = −1.39, 95% CI = −2.85 to 0.07, I 2 = 96.58%, 4 studies). Similarly, levels of ascorbic acid were comparable between patients with Plasmodium falciparum and Plasmodium vivax malaria ( p = 0.34, Cohen's d = −1.06, 95% CI = −3.23 to 1.12, I 2 = 97.30%, 3 studies).
Conclusions
The meta-analysis reveals diminished levels of ascorbic acid in malaria cases. Manipulating the host's nutritional status, such as by supplementing it with ascorbic acid to restore reactive oxygen species balance, may alter the progression of malarial infection and prevention of disease severity. Antioxid. Redox Signal. 40, 460–469.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Technology, School of Allied Health Sciences, Walailak University, Thai Buri, Nakhon Si Thammarat, Thailand.
- Department of Protozoology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University for Development Studies, Tamale, Ghana.
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP); Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.
- Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
ORCID-Profile: Manas Kotepui
Zitieren
APA
Kotepui, M., Mahittikorn, A., Anabire, N. G., Masangkay, F. R., & Kotepui, K. U. (2024). Malaria Is Associated with Diminished Levels of Ascorbic Acid: A Systematic Review and Meta-Analysis. Antioxidants & Redox Signaling, 40(7-9), 460-469. https://doi.org/10.1089/ars.2023.0306
Vancouver
Kotepui M, Mahittikorn A, Anabire NG, Masangkay FR, Kotepui KU. Malaria Is Associated with Diminished Levels of Ascorbic Acid: A Systematic Review and Meta-Analysis. Antioxidants & Redox Signaling. 2024;40(7-9):460-469. doi:10.1089/ars.2023.0306
BibTeX
@article{Kotepui2024,
author = {Kotepui, Manas and Mahittikorn, Aongart and Anabire, Nsoh Godwin and Masangkay, Frederick Ramirez and Kotepui, Kwuntida Uthaisar},
title = {Malaria Is Associated with Diminished Levels of Ascorbic Acid: A Systematic Review and Meta-Analysis},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {40},
number = {7-9},
pages = {460--469},
doi = {10.1089/ars.2023.0306}
}
EUVIMED